New tool "TCI SpectraViewer" | [Product Highlights] DMAPO as an Oxidant and... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product).
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 157716-52-4 | Product Number: P2831
Perifosine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 1,1-Dimethylpiperidin-1-ium-4-yl Octadecyl Phosphate
- 1,1-Dimethyl-4-piperidiniumyl Octadecyl Phosphate
Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 25MG |
₹9,000.00
|
Contact Us | 17 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | P2831 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__5H__5__2NO__4P = 461.67 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | -20°C |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Moisture Sensitive,Heat Sensitive |
| CAS RN | 157716-52-4 |
| Reaxys Registry Number | 11186113 |
| PubChem Substance ID | 468592745 |
| MDL Number | MFCD00927554 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC)(CAD) | min. 98.0 area% |
| Melting point | 230.0 to 234.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 232 °C |
GHS
Related Laws:
| RTECS# | TN5910000 |
Transport Information:
Application
Perifosine: An Oral Akt Inhibitor
The PI3K/Akt/mTOR pathway is aberrantly active in most human cancer cells and contributes to cancer cell growth, proliferation, and survival. Perifosine, an alkyl phospholipid, is an oral Akt inhibitor that display potent anti-proliferative activity in human tumor models. Perifosine has been shown to target phosphatidylinositol 3-kinase (PI3K)/Akt signaling. (The product is for research purpose only.)
References
- Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
- Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
- Perifosine: update on a novel Akt inhibitor (a review)
- Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity (a review)
- Current View on the Mechanism of Action of Perifosine in Cancer (a review)
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.